Featured Research

from universities, journals, and other organizations

Sports Medicine Specialists Pioneer New Treatment For Post-concussion Syndrome

Date:
October 18, 2006
Source:
University at Buffalo
Summary:
Sports medicine specialists in the University at Buffalo's Sports Medicine Institute have developed a new method for treating athletes who sustain post-concussion syndrome that, unlike the conventional approach, allows athletes to maintain conditioning while recovering gradually from the injury.

Sports medicine specialists in the University at Buffalo's Sports Medicine Institute have developed a new method for treating athletes who sustain post-concussion syndrome that, unlike the conventional approach, allows athletes to maintain conditioning while recovering gradually from the injury.

For unknown reasons, 5-10 percent of people who experience a concussion have symptoms that persist beyond six weeks. These people are diagnosed with post-concussion syndrome (PCS). Previously there has been no treatment for the condition with proven success.

"The most common approach by physicians is to recommend no exercise and prescribe antidepressants," said Barry Willer, Ph.D., UB professor of psychiatry and rehabilitation sciences. Willer is lead author on the paper describing the new method, published in the September issue of Current Treatment Options in Neurology.

"Most people with PCS have symptoms of depression," said Willer, "so anti-depressant treatment makes sense. However, antidepressants do little more than relieve some of the depression symptoms. We were interested in a treatment that didn't just treat the symptoms, but actually improved the patient's brain function."

The researchers call their new treatment "regulated exercise." The approach consists of determining the ideal exercise program for each athlete based on a number of individual physiological indicators at baseline.

Patients are tested every two to three weeks with specialized equipment at the sports medicine clinic to determine their progress, and a new program is developed based on those results.

Willer and co-author John Leddy, M.D., clinical associate professor of orthopaedics and rehabilitation sciences, indicated it is too early to call the treatment a cure, but they are optimistic about the results so far.

The researchers described the treatment method in mid-September at the 2006 Brain Injury Conference of the Americas in Miami, where the response was very favorable, according to Willer.

"Professionals at the meeting were delighted that our approach to treatment of post-concussion syndrome doesn't involve any medications and is very cost-efficient. We were surprised to learn that we are among only a few investigators interested in people with symptoms that won't go away.

"There is no other known treatment specifically for PCS, which we define as persistent symptoms of concussion past the time they should have cleared, usually around three weeks," said Willer. "As far as we can determine, there is only one other group in North America that is using regulated exercise as part of the treatment for PCS."

Willer and Leddy have used regulated exercise successfully with people who were as much as six months post-concussion. Their regimen is based on the hypothesis that the regulatory system responsible for maintaining cerebral blood flow, which may be dysfunctional in people with a concussion, can be restored to normal by controlled, graded symptom-free exercise.

"The treatment program is well tolerated by patients" Willer said. "Just being able to exercise often reduces the depressive symptoms. But it's imperative that the patient not go beyond the exercise limits.

"After the first three weeks of regulated exercise, we reassess the patient to see if there has been any change in physiology. The exercise program then is realigned successively to respond to the changes. In our experience thus far, symptoms disappear within several months for at least some of the patients," he said.

The specialists have worked with a small number of patients to date. They have included a UB soccer player who has returned to play and now is one of the team's leading scorers. Another young athlete was able to return to cross-country running and attend school full-time.

Willer, Leddy and other UB faculty members will present a half-day seminar on their treatment for concussion and post-concussion syndrome and the science behind it on Oct. 28 from 7:30 a.m. to noon in Butler Auditorium in Farber Hall on UB's South (Main Street) Campus.

The seminar, aimed primarily at physicians, also will be open to the public. Interested persons should contact the UB Office of Continuing Medical Education at 829-2378 or .edu for more information.


Story Source:

The above story is based on materials provided by University at Buffalo. Note: Materials may be edited for content and length.


Cite This Page:

University at Buffalo. "Sports Medicine Specialists Pioneer New Treatment For Post-concussion Syndrome." ScienceDaily. ScienceDaily, 18 October 2006. <www.sciencedaily.com/releases/2006/10/061012184808.htm>.
University at Buffalo. (2006, October 18). Sports Medicine Specialists Pioneer New Treatment For Post-concussion Syndrome. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2006/10/061012184808.htm
University at Buffalo. "Sports Medicine Specialists Pioneer New Treatment For Post-concussion Syndrome." ScienceDaily. www.sciencedaily.com/releases/2006/10/061012184808.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins